B-cell-derived IL-10 does not vitally contribute to the clinical course of glomerulonephritis

European Journal of Immunology

Volumn 44, Issue 3, 2014, Pages 683-693

  Kluger, Malte A ^a   Ostmann, Annett ^a   Luig, Michael ^a   Meyer, Matthias C ^a   Goerke, Boeren ^a   Paust, Hans Joachim ^a   Meyer Schwesinger, Catherine ^a   Stahl, Rolf A K ^a   Panzer, Ulf ^a   Tiegs, Gisa ^a   Steinmetz, Oliver M ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Autoimmunity; B cells; Glomerulonephritis; IL 10

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN G; INTERLEUKIN 10;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE COURSE; GLOMERULONEPHRITIS; HUMORAL IMMUNITY; IMMUNE RESPONSE; KIDNEY FUNCTION; LEUKOCYTE; MACROPHAGE; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; SPLEEN CELL; T LYMPHOCYTE ACTIVATION;

AUTOIMMUNITY; B CELLS; GLOMERULONEPHRITIS; IL-10;

ANIMALS; B-LYMPHOCYTES; CYTOKINES; DISEASE MODELS, ANIMAL; GLOMERULONEPHRITIS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; INTERLEUKIN-10; KIDNEY; LEUKOCYTES; MALE; MICE; MICE, TRANSGENIC;

EID: 84896030166     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201343842     Document Type: Article

References (51)

1. Townsend, M. J., Monroe, J. G. and Chan, A. C., B-cell targeted therapies in human autoimmune diseases: an updated perspective. Immunol. Rev. 2010. 237: 264-283.
2. Steinmetz, O. M., Stahl, R. A. and Panzer, U., Chemokines and B cells in renal inflammation and allograft rejection. Front. Biosci. (Schol. Ed.) 2009. 1: 13-22.
3. Steinmetz, O. M., Velden, J., Kneissler, U., Marx, M., Klein, A., Helmchen, U., Stahl, R. A. et al., Analysis and classification of B-cell infiltrates in lupus and ANCA-associated nephritis. Kidney Int. 2008. 74: 448-457.
4. Kattah, A. G., Fervenza, F. C. and Roccatello, D., Rituximab-based novel strategies for the treatment of immune-mediated glomerular diseases. Autoimmun. Rev. 2013. 12: 854-859.
5. Navarra, S. V., Guzman, R. M., Gallacher, A. E., Hall, S., Levy, R. A., Jimenez, R. E., Li, E. K. et al., Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial. Lancet 2011. 377: 721-731.
6. Clatworthy, M. R., Targeting B cells and antibody in transplantation. Am. J. Transplant. 2011. 11: 1359-1367.
7. Clatworthy, M. R., Watson, C. J., Plotnek, G., Bardsley, V., Chaudhry, A. N., Bradley, J. A. and Smith, K. G., B-cell-depleting induction therapy and acute cellular rejection. N. Engl. J. Med. 2009. 360: 2683-2685.
8. Mizoguchi, A., Mizoguchi, E., Takedatsu, H., Blumberg, R. S. and Bhan, A. K., Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 2002. 16: 219-230.
9. DiLillo, D. J., Matsushita, T. and Tedder, T. F., B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann. N.Y. Acad. Sci. 2010. 1183: 38-57.
10. Mauri, C. and Bosma, A., Immune regulatory function of B cells. Annu. Rev. Immunol. 2012. 30: 221-241.
11. + phenotype controls T cell-dependent inflammatory responses. Immunity 2008. 28: 639-650.
12. Mauri, C., Gray, D., Mushtaq, N. and Londei, M., Prevention of arthritis by interleukin 10-producing B cells. J. Exp. Med. 2003. 197: 489-501.
13. Yanaba, K., Yoshizaki, A., Asano, Y., Kadono, T., Tedder, T. F. and Sato, S., IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model. Am. J. Pathol. 2011. 178: 735-743.
14. Matsushita, T., Horikawa, M., Iwata, Y. and Tedder, T. F., Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis. J. Immunol. 2010. 185: 2240-2252.
15. Haas, K. M., Watanabe, R., Matsushita, T., Nakashima, H., Ishiura, N., Okochi, H., Fujimoto, M. et al., Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice. J. Immunol. 2010. 184: 4789-4800.
16. Watanabe, R., Ishiura, N., Nakashima, H., Kuwano, Y., Okochi, H., Tamaki, K., Sato, S. et al., Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity. J. Immunol. 2010. 184: 4801-4809.
17. Matsushita, T., Yanaba, K., Bouaziz, J. D., Fujimoto, M. and Tedder, T. F., Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J. Clin. Invest. 2008. 118: 3420-3430.
18. Iwata, Y., Matsushita, T., Horikawa, M., Dilillo, D. J., Yanaba, K., Venturi, G. M., Szabolcs, P. M. et al., Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 2011. 117: 530-541.
19. Das, A., Ellis, G., Pallant, C., Lopes, A. R., Khanna, P., Peppa, D., Chen, A. et al., IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection. J Immunol 2012. 189: 3925-3935.
20. Blair, P. A., Norena, L. Y., Flores-Borja, F., Rawlings, D. J., Isenberg, D. A., Ehrenstein, M. R. and Mauri, C., CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 2010. 32: 129-140.
21. Bunch, D. O., McGregor, J. G., Khandoobhai, N. B., Aybar, L. T., Burkart, M. E., Hu, Y., Hogan, S. L. et al., Decreased CD5(+) B cells in active ANCA vasculitis and relapse after rituximab. Clin. J. Am. Soc. Nephrol. 2013. 8: 382-391.
22. Carter, N. A., Rosser, E. C. and Mauri, C., Interleukin-10 produced by B cells is crucial for the suppression of Th17/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis. Arthritis Res. Ther. 2012. 14: R32.
23. Carter, N. A., Vasconcellos, R., Rosser, E. C., Tulone, C., Munoz-Suano, A., Kamanaka, M., Ehrenstein, M. R. et al., Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J. Immunol. 2011. 186: 5569-5579.
24. Gray, M., Miles, K., Salter, D., Gray, D. and Savill, J., Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells. Proc. Natl. Acad. Sci. USA 2007. 104: 14080-14085.
25. Blair, P. A., Chavez-Rueda, K. A., Evans, J. G., Shlomchik, M. J., Eddaoudi, A., Isenberg, D. A., Ehrenstein, M. R. et al., Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. J. Immunol. 2009. 182: 3492-3502.
26. Lemoine, S., Morva, A., Youinou, P. and Jamin, C., Human T cells induce their own regulation through activation of B cells. J. Autoimmun. 2011. 36: 228-238.
27. Matsushita, Y., Hasegawa, M., Matsushita, T., Fujimoto, M., Horikawa, M., Fujita, T., Kawasuji, A. et al., Intercellular adhesion molecule-1 deficiency attenuates the development of skin fibrosis in tight-skin mice. J. Immunol. 2007. 179: 698-707.
28. Yanaba, K., Bouaziz, J. D., Matsushita, T., Tsubata, T. and Tedder, T. F., The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J. Immunol. 2009. 182: 7459-7472.
29. Horikawa, M., Weimer, E. T., DiLillo, D. J., Venturi, G. M., Spolski, R., Leonard, W. J., Heise, M. T. et al., Regulatory B cell (B10 Cell) expansion during Listeria infection governs innate and cellular immune responses in mice. J. Immunol. 2013. 190: 1158-1168.
30. Yoshizaki, A., Miyagaki, T., DiLillo, D. J., Matsushita, T., Horikawa, M., Kountikov, E. I., Spolski, R. et al., Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature 2012. 491: 264-268.
31. Ostmann, A., Paust, H. J., Panzer, U., Wegscheid, C., Kapffer, S., Huber, S., Flavell, R. A. et al., Regulatory T cell-derived IL-10 ameliorates crescentic GN. J. Am. Soc. Nephrol. 2013. 24: 930-942.
32. Teichmann, L. L., Kashgarian, M., Weaver, C. T., Roers, A., Muller, W. and Shlomchik, M. J., B cell-derived IL-10 does not regulate spontaneous systemic autoimmunity in MRL.Fas(lpr) mice. J. Immunol. 2012. 188: 678-685.
33. Cochrane, C. G., Unanue, E. R. and Dixon, F. J., A role of polymorphonuclear leukocytes and complement in nephrotoxic nephritis. J. Exp. Med. 1965. 122: 99-116.
34. Kitching, A. R., Tipping, P. G., Timoshanko, J. R. and Holdsworth, S. R., Endogenous interleukin-10 regulates Th1 responses that induce crescentic glomerulonephritis. Kidney Int. 2000. 57: 518-525.
35. Kitching, A. R., Tipping, P. G., Huang, X. R., Mutch, D. A. and Holdsworth, S. R., Interleukin-4 and interleukin-10 attenuate established crescentic glomerulonephritis in mice. Kidney Int. 1997. 52: 52-59.
36. Assmann, K. J., Tangelder, M. M., Lange, W. P., Schrijver, G. and Koene, R. A., Anti-GBM nephritis in the mouse: severe proteinuria in the heterologous phase. Virchows Arch. A Pathol. Anat. Histopathol. 1985. 406: 285-299.
37. Tipping, P. G. and Holdsworth, S. R., T cells in crescentic glomerulonephritis. J. Am. Soc. Nephrol. 2006. 17: 1253-1263.
38. Turner, J. E., Paust, H. J., Steinmetz, O. M. and Panzer, U., The Th17 immune response in renal inflammation. Kidney Int. 2010. 77: 1070-1075.
39. Kitching, A. R., Holdsworth, S. R. and Tipping, P. G., Crescentic glomerulonephritis - a manifestation of a nephritogenic Th1 response? Histol. Histopathol. 2000. 15: 993-1003.
40. Maseda, D., Smith, S. H., DiLillo, D. J., Bryant, J. M., Candando, K. M., Weaver, C. T. and Tedder, T. F., Regulatory B10 cells differentiate into antibody-secreting cells after transient IL-10 production in vivo. J. Immunol. 2012. 188: 1036-1048.
41. Briere, F., Servet-Delprat, C., Bridon, J. M., Saint-Remy, J. M. and Banchereau, J., Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3. J. Exp. Med. 1994. 179: 757-762.
42. Rickert, R. C., Roes, J. and Rajewsky, K., B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res. 1997. 25: 1317-1318.
43. Madan, R., Demircik, F., Surianarayanan, S., Allen, J. L., Divanovic, S., Trompette, A., Yogev, N. et al., Nonredundant roles for B cell-derived IL-10 in immune counter-regulation. J. Immunol. 2009. 183: 2312-2320.
44. Rubtsov, Y. P., Rasmussen, J. P., Chi, E. Y., Fontenot, J., Castelli, L., Ye, X., Treuting, P. et al., Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 2008. 28: 546-558.
45. Kamanaka, M., Kim, S. T., Wan, Y. Y., Sutterwala, F. S., Lara-Tejero, M., Galan, J. E., Harhaj, E. et al., Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse. Immunity 2006. 25: 941-952.
46. Panzer, U., Steinmetz, O. M., Paust, H. J., Meyer-Schwesinger, C., Peters, A., Turner, J. E., Zahner, G. et al., Chemokine receptor CXCR3 mediates T cell recruitment and tissue injury in nephrotoxic nephritis in mice. J. Am. Soc. Nephrol. 2007. 18: 2071-2084.
47. Turner, J. E., Paust, H. J., Steinmetz, O. M., Peters, A., Meyer-Schwesinger, C., Heymann, F., Helmchen, U. et al., CCR5 deficiency aggravates crescentic glomerulonephritis in mice. J. Immunol. 2008. 181: 6546-6556.
48. Steinmetz, O. M., Summers, S. A., Gan, P. Y., Semple, T., Holdsworth, S. R. and Kitching, A. R., The Th17-defining transcription factor RORgammat promotes glomerulonephritis. J. Am. Soc. Nephrol. 2011. 22: 472-483.
49. + T-cell response in experimental autoimmune glomerulonephritis. Kidney Int. 2012. 82: 60-71.
50. Turner, J. E., Paust, H. J., Steinmetz, O. M., Peters, A., Riedel, J. H., Erhardt, A., Wegscheid, C. et al., CCR6 recruits regulatory T cells and Th17 cells to the kidney in glomerulonephritis. J. Am. Soc. Nephrol. 2010. 21: 974-985.
51. Kluger, M. A., Zahner, G., Paust, H. J., Schaper, M., Magnus, T., Panzer, U. and Stahl, R. A., Leukocyte-derived MMP9 is crucial for the recruitment of proinflammatory macrophages in experimental glomerulonephritis. Kidney Int. 2013. 83: 865-877.